Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Challenging Clinical Case in Antimicrobial Resistance"'
Autor:
Ahnika Kline, Michail S. Lionakis
Publikováno v:
Antimicrob Agents Chemother
Aspergillus calidoustus is an emerging, azole-resistant, cryptic Aspergillus species in immunosuppressed patients that often features extrapulmonary involvement and carries high mortality. The case presented by J. F. Camargo, R. Jabr, A. D. Anderson,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00298fe8d449394370602bdf9cfa4351
https://europepmc.org/articles/PMC8923175/
https://europepmc.org/articles/PMC8923175/
Autor:
Jose F. Camargo, Ra’ed Jabr, Anthony D. Anderson, Lazaros Lekakis, Meilin Diaz-Paez, Laurence M. Briski, Mohammed Raja, Michele I. Morris, Krishna V. Komanduri, Denise Pereira
Publikováno v:
Antimicrob Agents Chemother
Antimicrobial agents and chemotherapy, vol 66, iss 3
Antimicrobial agents and chemotherapy, vol 66, iss 3
Invasive aspergillosis is the most common invasive mold infection following a hematopoietic cell transplant. Widespread use of antifungal prophylaxis has led to the increasing incidence of cryptic Aspergillus species. Aspergillus calidoustus is one o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d3a5cedace5833a8ba576dbc40c32c8
https://doi.org/10.1128/aac.02206-21
https://doi.org/10.1128/aac.02206-21
Autor:
Michael J Brownstein, Jason W. Bennett, Yetunde O Kare-Opaneye, Sohail Rao, Monica M. Betancourt-Garcia, Bri'Anna Horne, Joseph Fackler, Lia Patricia Suazo Hernandez, Brett E Swiercezewski
Publikováno v:
Antimicrob Agents Chemother
Hospitalized patients are at risk of developing serious multidrug resistant bacterial infections. This risk is heightened in patients who are on mechanical ventilation, are immunocompromised, and/or have chronic comorbidities. We report the case of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::437424e042eee850147f909d854f2463
https://europepmc.org/articles/PMC8765271/
https://europepmc.org/articles/PMC8765271/
Autor:
Brianna M. Eales, Vincent H. Tam
Publikováno v:
Antimicrob Agents Chemother
Acinetobacter baumannii is a pathogenic bacterium commonly associated with multidrug resistance. In this issue of Antimicrobial Agents and Chemotherapy , a challenging case of ventilator-associated pneumonia is presented in which bacteriophage therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::947042030a80c692343f651770f60b86
https://doi.org/10.1128/aac.01996-21
https://doi.org/10.1128/aac.01996-21
Publikováno v:
Antimicrob Agents Chemother
Carbapenem-resistant Acinetobacter baumannii (CRAB) infections are challenging to treat and associated with poor clinical outcomes. In this issue, sulbactam-durlobactam, a novel β-lactam-β-lactamase inhibitor, was used with cefiderocol to successfu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6742058d85adf1885d43e66d5669acc
https://doi.org/10.1128/aac.01424-21
https://doi.org/10.1128/aac.01424-21
Publikováno v:
Antimicrob Agents Chemother
Extremely drug-resistant (XDR) Acinetobacter baumannii causes challenging nosocomial infections. We report the case of a patient with XDR A. baumannii pneumonia and septic shock successfully treated with cefiderocol and a novel antibiotic obtained vi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8c2f7e9165e935372c28a71a7f6557c
https://pubmed.ncbi.nlm.nih.gov/34370576
https://pubmed.ncbi.nlm.nih.gov/34370576
Autor:
George Sakoulas
Publikováno v:
Antimicrob Agents Chemother
Given that it is unlikely that randomized clinical trials will yield answers for treating the most challenging bacteremic infections caused by methicillin-resistant Staphylococcus aureus , clinicians, microbiologists, and pharmacists will have to coo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ccfd53dc87cc22effb698a1dfcaa75a
https://europepmc.org/articles/PMC7927839/
https://europepmc.org/articles/PMC7927839/
Autor:
Steven Y. C. Tong, Arnold S. Bayer
Publikováno v:
Antimicrob Agents Chemother
Staphylococcus argenteus infection was initially described in Aboriginal patients in the Northern Territories of Australia as a predominant cause of skin infections and is rare outside Southeast Asia. A first well-characterized case of S. argenteus i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94192ca9a49b9ba09e0ce32d1c4fd905
https://doi.org/10.1128/aac.01502-20
https://doi.org/10.1128/aac.01502-20
Autor:
Amy Lyden, Mazin Abdelghany, Rene Sit, Samantha Hao, Sarah B Doernberg, Joseph L. DeRisi, Charles Langelier, Michelle Tan, Steve Miller, Cristina M. Tato
Publikováno v:
Antimicrobial agents and chemotherapy, vol 64, iss 10
Antimicrob Agents Chemother
Antimicrob Agents Chemother
Staphylococcus argenteus is a novel staphylococcal species associated with invasive disease. We report the first case of daptomycin/vancomycin-resistant S. argenteus , initially speciated as Staphylococcus aureus , that developed from repeated treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::043af54cbcf44b7374fc8e6266435a83
https://escholarship.org/uc/item/0400j2bw
https://escholarship.org/uc/item/0400j2bw
Autor:
Ryan K. Shields
Publikováno v:
Antimicrob Agents Chemother
Cefiderocol is a newly approved siderophore cephalosporin that demonstrates expanded in vitro activity against multidrug-resistant Gram-negative bacteria. In two challenging cases reported here, cefiderocol shows potential utility as salvage therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2b5006f52ed1ba5476691d9fd65779e
https://doi.org/10.1128/aac.00059-20
https://doi.org/10.1128/aac.00059-20